Long-term pneumatic stenting with positive expiratory pressure therapy for severe expiratory central airway collapse.
Rodrigo Funes-FerradaAlanna Barrios-RuizAlejandra Yu Lee-MateusMargaret M JohnsonSebastian Fernandez-BussyDavid Abia-TrujilloPublished in: Respirology case reports (2024)
Expiratory central airway collapse (ECAC) comprising excessive central airway collapse (EDAC) and tracheobronchomalacia. Treatment is challenging for severe cases that are not candidates for surgical management. We report a case of severe ECAC successfully managed with continuous positive airway pressure (CPAP) therapy. A 75-year-old female patient status post right pneumonectomy, presented with chronic cough. Dynamic bronchoscopy evaluation showed severe EDAC which improved with intraprocedural noninvasive positive pressure (NIPPV) therapy. Due to patients' comorbidities, she was not a candidate to surgical tracheobronchoplasty. Therefore, we attempted pneumatic stenting with long-term CPAP therapy resulting in improvement of symptoms and functional capacity. The long-term efficacy of pneumatic stenting has not been clearly established yet. Literature review of management of ECAC with NIPPV consist primarily of case reports and there is only one clinical trial being conducted to assess the efficacy of CPAP therapy in ECAC. While NIPPV arises as a sufficient alternative for management of severe ECAC, larger scale studies are needed to prove the real efficacy of NIPPV in this setting.
Keyphrases
- positive airway pressure
- obstructive sleep apnea
- clinical trial
- early onset
- sleep apnea
- case report
- end stage renal disease
- stem cells
- chronic kidney disease
- drug induced
- newly diagnosed
- ejection fraction
- mechanical ventilation
- prognostic factors
- mesenchymal stem cells
- intensive care unit
- bone marrow
- acute coronary syndrome
- percutaneous coronary intervention
- physical activity